No significant difference was found in the blood glucose–lowering ratio between insulin glargine (0.23 mg/dL/unit) as compared with insulin detemir (0.16 mg/dL/unit P =. Results: Fifty-two patients were included in this study. A blood glucose–lowering ratio for both insulin glargine and insulin detemir was calculated for each patient based off of up to 5 days of fasting blood glucose values and the total number of units of insulin administered. Patients must have received both insulin detemir and insulin glargine on either the same or separate hospital visits. Methods: This institutional review board-approved, single-center, retrospective, case-crossover study was conducted in patients with diabetes mellitus with inpatient admissions between June 30, 2014, to July 1, 2015. Objectives: To determine the ratio of glucose lowering between insulin detemir and insulin glargine. However, controversy remains as to whether the 2 agents are comparable with regard to unit equivalency. While these analogs chemically differ, clinical trials have established no significant difference in efficacy. Background: Insulin glargine and insulin detemir are the most commonly prescribed basal insulins in the United States.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |